Press Releases

GlobeNewswire, Inc.

Study demonstrates feasibility of saline-based hybrid IVUS-OCT imaging without iodinated contrast during image acquisition FDA-cleared OCTIV system now in commercial clinical use, with patient cases ongoing TORONTO, Nov. 03, 2026 (GLOBE NEWSWIRE)...

GlobeNewswire, Inc.

Presentation at AHA on Nov. 9 to highlight cardiac outcomes following a single dose of nex-z in patients with ATTRv-PN with mixed phenotype from the Phase 1 clinical trial Presentation at ISA on Nov. 18 to include up to four years of follow-up...

North Carolina Office of the Governor

NORTH CAROLINA, November 2 - The NC Department of Health and Human Services today launched a new dashboard sharing all projects that were awarded Rural Health Transformation Program funds in Year 1, along with the counties served, the amounts...

GlobeNewswire, Inc.

NASHVILLE, Tenn., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Clearsense®, a leading healthcare data enablement platform company, has earned a spot on TIME’s list of the World’s Top HealthTech Companies for the second year in a row. The global ranking is...

GlobeNewswire, Inc.

FOSTER CITY, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a hematology-focused biopharmaceutical company pursuing more meaningful moments for people living with blood cancer, today announced that members of the...

GlobeNewswire, Inc.

LA JOLLA, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- CalciMedica, Inc. (“CalciMedica” or the “Company”) (Nasdaq: CALC), a clinical-stage biopharmaceutical company developing novel calcium release-activated calcium (CRAC) channel inhibition...

GlobeNewswire, Inc.

NEW YORK and TORONTO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Helus Pharma Inc. (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or “Helus Pharma”), a clinical-stage pharmaceutical company committed to improving the treatment landscape in mental health...

GlobeNewswire, Inc.

ROCKVILLE, Md., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery,...

GlobeNewswire, Inc.

WAYNE, Pa., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (Palvella or the “Company”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies for serious, rare skin...

GlobeNewswire, Inc.

SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc. (Nasdaq: BLSM), a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to design and develop innovative small molecule medicines for...

GlobeNewswire, Inc.

CAMBRIDGE, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Parabilis Medicines (Nasdaq: PBLS), a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking historically...

GlobeNewswire, Inc.

DALLAS, Nov. 03, 2026 (GLOBE NEWSWIRE) -- IMS Legal Strategies (IMS) announces a new expansion of its fast-growing Life Care Planning services and a continuation of its overall growth strategy, with the acquisition of Medical & Life Care...

GlobeNewswire, Inc.

DALLAS, Nov. 03, 2026 (GLOBE NEWSWIRE) -- IMS Legal Strategies (IMS) announces a new expansion of its fast-growing services, and a continuation of its overall growth strategy, with the acquisition of Medical & Life Care Consulting Services (MLCC),...

GlobeNewswire, Inc.

BOSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX) today announced that Malte Peters, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a fireside chat at Guggenheim’s...

EIN Presswire

ATLANTA, GA, UNITED STATES, November 3, 2026 /⁨EINPresswire.com⁩/ -- Etherio is pleased to welcome the American Association of Pharmaceutical Scientists (AAPS) as the newest client in its association management portfolio.

GlobeNewswire, Inc.

PRINCETON, N.J., Nov. 03, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that Nikhil Lalwani, President and Chief Executive Officer, along with members of the Company’s executive leadership...

GlobeNewswire, Inc.

Peer-reviewed publication reports a 77% relative risk reduction in bloodstream infections and significantly lower systemic antibiotic exposure with SER-155 compared with placebo Translational data from the study support the SER-155 mechanisms of...

GlobeNewswire, Inc.

Third-quarter 2026 Rezdiffra® (resmetirom) net sales of $431.3 million, representing year-over-year growth of 50%; achieved first quarter of profitability Rezdiffra reaches a major milestone, achieving blockbuster status with year-to-date net...

GlobeNewswire, Inc.

-- Strong U.S. launch momentum for IMCIVREE® (setmelanotide) for acquired hypothalamic obesity (HO) continues with more than 700 patient start forms as of September 30, 2026 -- -- Third quarter 2026 net product revenue from global sales of...

GlobeNewswire, Inc.

Q3 2026 net revenues increased 4.4% on both an as-reported and constant currency basis(1), compared to Q3 2025 Q3 2026 net income of $58 million or $0.20 per diluted share Q3 2026 Adjusted EBITDA(1) increased 3.9%, or 4.0% on a constant currency...